-
Company Nameaiwell Inc.
-
EstablishmentJanuary 23, 2018
-
RepresentativeHIROYUKI MABUCHI
-
Location
-
Head Office
〒105-0012 - Branch Office Sapporo
- Proteomics Innovation Center(PIC) PIC Shin-Kawasaki
Room 613, H¹O Hamamatsucho
1-2-14 Shibadaimon, Minato-ku, Tokyo
〒060-0908
4-1-20 Kitahachijo Higashi, Higashi-ku, Sapporo-shi, Hokkaido
2nd Floor, Satudora Holdings
EZOHUB SAPPORO
Room 221, KBIC Main Building, 7-7 Shin-Kawasaki,
Saiwai-ku, Kawasaki, Kanagawa 212-0032, Japan
KBIC Access Map & Location Info -
Head Office
-
Capital
-
Main ShareholderRepresentative, Yokogawa Electric Corporation, Burroughs Inc, DIGIMERCE Inc, Taisho Pharmaceutical Co., Ltd., Future Food Fund Inc.,North Pacific Bank, Ltd., Contrail LLC, and individual investors
-
Business description
- Realization of mass image data intercomparison by digital imaging and analysis of proteins from human, animals and other living organisms from trace amounts of samples in collaboration with Institute of Science Tokyo.
- Providing services to support drug discovery, diagnosis and remote medical care using AI before worsening of symptoms or onset of subjective symptoms under the mission 「Eliminating illnesses from the world and keep people healthy」
-
SuppliersInstitute of Science Tokyo, Sapporo Medical University, Consadole Co., Ltd., R-body project, Kirin Holdings Co., Ltd., Yokogawa Electric Corporation. Sumitomo Dainippon Pharma Co., Ltd. Taisho Pharmaceutical Co., Ltd.